SINOPHARM: (1) CONTINUING CONNECTED TRANSACTION: ENTERING INTO THE 2020 PROCUREMENT FRAMEWORK AGREEMENT; (2) DISCLOSEABLE TRANSACTION AND CONTINUING CONNECTED TRANSACTION: ENTERING INTO THE 2020 FINANCIAL SERVICES FRAMEWORK AGREEMENT; AND NOTICE OF EGM

Nov 27, 2020 06:38

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

國藥控股：(1) 持續關連交易：簽訂二零二零年採購框架協議； (2) 須予披露交易及持續關連交易：簽訂二零二零年金融服務框架協議；及 股東特別大會通告

SINOPHARM: (1) CONTINUING CONNECTED TRANSACTION: ENTERING INTO THE 2020 PROCUREMENT FRAMEWORK AGREEMENT; (2) DISCLOSEABLE TRANSACTION AND CONTINUING CONNECTED TRANSACTION: ENTERING INTO THE 2020 FINANCIAL SERVICES FRAMEWORK AGREEMENT; AND NOTICE OF EGM

Risk Disclaimer

Statement

國藥控股：(1) 持續關連交易：簽訂二零二零年採購框架協議； (2) 須予披露交易及持續關連交易：簽訂二零二零年金融服務框架協議；及股東特別大會通告